On May 11, 2023, the APST ALS Network Meeting will take place in Berlin, followed directly by the MND-Net Meeting. The APST Network Meeting and the MND-Net Meeting serve to discuss current
Why is the biomarker NfL important for people with ALS? The value of the biomarker Neurofilament light chain (NfL) in the blood is suitable for assessing the progression and therapy of ALS. A
We would like to briefly update you on the current status (03/01/2023) of the ID-ALS02 study and the transition to the Tofersen Hardship Program After the successful completion of the first part
Since August 2022, our supply network has been using a so-called outreach care management established for people with ALS. In the model project, patients who require complex care but receive
we have added the display of vital signs for nutrition and respiration as a new feature in the ALS app. The current version of the ALS app (version 4.0.8) is available for download free of
